CD79A and synovial sarcoma: In addition to B lymphocyte hyperactivity, dysregulation of polymeric IgA production may be a key pathogenetic factor when SS and IgAN co-occur.[8] Watanabe et al[13] proposed that co-occurring SS and IgAN had a genetic basis.